Finance

Lists
0546:HKG
Fufeng Group Ltd
HK$4.65
+0.43%
(+0.020) 1D
Sep 4, 4:08:01 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 0546...
Open
HK$4.63
High
HK$4.80
Low
HK$4.63
Mkt. cap
11.66B
Avg. vol.
0.00
Volume
5.54M
Dividend
3.51%
Quarterly dividend
HK$0.04
Ex-dividend date
Sep 10, 2025
P/E ratio
9.80
52-wk high
HK$10.14
52-wk low
HK$4.41
EPS
HK$0.47
Shares outstanding
2.55B
No. of employees
17K
Open
HK$4.63
High
HK$4.80
Low
HK$4.63
Mkt. cap
11.66B
Avg. vol.
0.00
Volume
5.54M
Dividend
3.51%
Quarterly dividend
HK$0.04
Ex-dividend date
Sep 10, 2025
P/E ratio
9.80
52-wk high
HK$10.14
52-wk low
HK$4.41
EPS
HK$0.47
Shares outstanding
2.55B
No. of employees
17K
Profile
Fufeng Group Limited is a publicly listed Chinese multinational bio-fermentation company. It is one of the world's largest producers of monosodium glutamate and xanthan gum. Incorporated in the Cayman Islands and headquartered in Qingdao, Shandong Province, the company's core business is the large-scale transformation of corn into a range of industrial ingredients for the food, animal nutrition, and pharmaceutical industries. Founded in 1999 by Li Xuechun from the assets of a former state-owned MSG factory in Shandong, Fufeng Group has grown from a regional manufacturer into a global company. The company was listed on the Main Board of the Hong Kong Stock Exchange on February 8, 2007. Its products are distributed across China and exported to over 100 countries and regions worldwide, with an annual outbound logistics volume exceeding 5 million tons. By 2024, the group's total operating revenue was approximately RMB 27.8 billion. The company holds a significant position in the global MSG market. Fufeng is also one of the world's leading producers of xanthan gum. Wikipedia
About Fufeng Group Ltd
CEO-
Employees17K
Founded1999
Headquarters-
SectorChemical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.96B
6.96B
6.90B
6.90B
Cost of goods sold
5.80B
5.80B
5.72B
5.72B
Cost of revenue
5.80B
5.80B
5.72B
5.72B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
915.72M
915.72M
877.90M
877.90M
Operating expense
832.23M
832.23M
1.02B
1.02B
Total operating expenses
6.64B
6.64B
6.74B
6.74B
Operating income
324.46M
324.46M
159.17M
159.17M
Other non operating income
-5.62M
-5.62M
124.27M
124.27M
EBT including unusual items
417.58M
417.58M
204.77M
204.77M
EBT excluding unusual items
264.69M
264.69M
204.77M
204.77M
Income tax expense
80.83M
80.83M
31.49M
31.49M
Effective tax rate
19.36%
19.36%
15.38%
15.38%
Other operating expenses
-71.67M
-71.67M
143.69M
143.69M
Net income
336.74M
336.74M
173.28M
173.28M
Net profit margin
4.84%
4.84%
2.51%
2.51%
Earnings per share
-
-
-
-
Interest and investment income
143.42M
143.42M
-
-
Interest expense
-62.47M
-62.47M
-78.37M
-78.37M
Net interest expenses
80.95M
80.95M
-78.37M
-78.37M
Depreciation and amortization charges
-
-
-
-
EBITDA
636.78M
636.78M
475.77M
475.77M
Gain or loss from assets sale
-35.96M
-35.96M
-
-
AI content may include mistakes. Learn more
Google apps